Comparative Analysis of Diverse Additives in High-Strength Concrete
International Journal of Advanced Research in Science Communication and Technology · 13.05.2026 · 207
DOI: 10.48175/ijarsct-35330 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Advanced Research in Science Communication and Technology, online erschienen am 13.05.2026. Verfasst von Dr. A. J. Mehetre and Dhamale Prasanna Mohit. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
High-strength concrete (HSC) is widely used in modern construction due to its high strength, durability, and long service life. This study presents a comparative analysis of additives such as GGBS, Alccofine, used in HSC to improve compressive strength, workability, and durability. Experimental results show that silica fume, metakaolin, and Alccofine significantly enhance strength and reduce permeability due to their pozzolanic and micro-filling properties, while fly ash and GGBS improve workability and long-term durability. Superplasticizers improve concrete flow without increasing the water-cement ratio. The study concludes that the proper combination of mineral and chemical admixtures can produce sustainable, durable, and high-performance concrete for advanced construction applications
Zitieren
APA
Mohit, D. A. J. M. A. D. P. (2026). Comparative Analysis of Diverse Additives in High-Strength Concrete. International Journal of Advanced Research in Science Communication and Technology, 207. https://doi.org/10.48175/ijarsct-35330
Vancouver
Mohit DAJMADP. Comparative Analysis of Diverse Additives in High-Strength Concrete. International Journal of Advanced Research in Science Communication and Technology. 2026:207. doi:10.48175/ijarsct-35330
BibTeX
@article{Mohit2026,
author = {Mohit, Dr. A. J. Mehetre and Dhamale Prasanna},
title = {Comparative Analysis of Diverse Additives in High-Strength Concrete},
journal = {International Journal of Advanced Research in Science Communication and Technology},
year = {2026},
pages = {207},
doi = {10.48175/ijarsct-35330}
}
EUVIMED